Abstract:Background Predicting clinical outcomes after cardiac resynchronization therapy (CRT) and its optimization remain a challenge. We sought to determine whether pre‐ and postimplantation QRS area (QRS area ) predict clinical outcomes after CRT. Methods and Results In this retrospective study, QRS area , derived from pre‐ and postimplantation vectorcardiography, were assessed in relation to the primary end point of cardiac mortality after CRT with or without defibrillation. Other end points included total mortality, total mortality or heart failure (HF) hospitalization, total mortality or major adverse cardiac events, and the arrhythmic end point of sudden cardiac death or ventricular arrhythmias with or without a shock. In patients (n=380, age 72.0±12.4 years, 68.7% male) undergoing CRT over 7.7 years (median follow‐up: 3.8 years [interquartile range 2.3–5.3]), preimplantation QRS area ≥102 μVs predicted cardiac mortality (HR: 0.36; P <0.001), independent of QRS duration (QRSd) and morphology ( P <0.001). A QRS area reduction ≥45 μVs after CRT predicted cardiac mortality (HR: 0.19), total mortality (HR: 0.50), total mortality or heart failure hospitalization (HR: 0.44), total mortality or major adverse cardiac events (HR: 0.43) (all P <0.001) and the arrhythmic end point (HR: 0.26; P <0.001). A concomitant reduction in QRS area and QRSd was associated with the lowest risk of cardiac mortality and the arrhythmic end point (both HR: 0.12, P <0.001). Conclusions Pre‐implantation QRS area , derived from vectorcardiography, was superior to QRSd and QRS morphology in predicting cardiac mortality after CRT. A postimplant reduction in both QRS area and QRSd was associated with the best outcomes, including the arrhythmic end point. Clinical Perspective What Is New? Pre‐implantation QRS area was superior to QRSd and QRS morphology in predicting cardiac and total mortality after cardiac resynchronization therapy. Concomitant reductions in QRS area and QRSd after cardiac resynchronization therapy were associated with the best survival and the lowest risk of heart failure hospitalization, major adverse cardiac events as well as ventricular arrhythmias. What Are the Clinical Implications? Reductions in QRS area and QRSd could be a focus for optimization after cardiac resynchronization therapy implantation. Introduction Cardiac resynchronization therapy (CRT) is an established treatment for patients with heart failure (HF), impaired left ventricular (LV) function, and a wide QRS complex. 1 As with any medical therapy, its treatment effect is variable. "Nonresponder" rates range from 9% to 68%, depending on the criteria used to define response. 2 Although no medical therapy can be expected to be 100% effective, there is a consensus view that response to CRT can be improved. 3 Manifold imaging studies explored mechanical dyssynchrony in relation to patient selection and optimization but, ultimately, no single measure of mechanical dyssynchrony has been adopted by clinical guidelines. 4 In this context, we should consider CRT is an electrical treatment and that its substrate should be electrical rather than mechanical. In this respect, QRS duration (QRSd) has been adopted as a surrogate of electrical dyssynchrony in randomized, controlled trials, 1 and a reduction in QRSd has been shown to predict better long‐term outcomes after CRT. 5 , 6 Evidence has recently emerged in support of vectorcardiography in the field of CRT. In this respect, QRS area (QRS area ) has been shown to correlate with LV lateral wall activation time, 7 the maximum rate of rise of LV pressure (ΔLV dP/dt max ), 8 , 9 and LV reverse remodeling<a class="tab-li -Abstract Truncated-

Interaction of left ventricular size with the outcome of cardiac resynchronization therapy in Japanese patients

Clinical Utility of QRS Duration Normalized to Left Ventricular Volume for Predicting Cardiac Resynchronization Therapy Efficacy in Patients with "Mid-Range" QRS Duration

[Factors Associated with the Efficacy of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure].

The clinical effect of quadripolar left ventricular lead in CRT therapy

Relationship between Sex, Body Size, and Cardiac Resynchronization Therapy Benefit: A Patient Level Meta-Analysis of Randomized Controlled Trials

Value of QRS duration in predicting response to cardiac resynchronization therapy in patients with end-stage heart failure

Delta QRS and outcomes post CRT in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial

Predictors for Cardiac Resynchronization Therapy Response

CRT Efficacy in “Mid-Range” QRS Duration among Asians Contrasted to Non-Asians, and Influence of Height

Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy

Impact of postoperative QRS duration change on cardiac resynchronization therapy

Comparison of Left Ventricular Reverse Remodeling Induced by Cardiac Contractility Modulation and Cardiac Resynchronization Therapy in Heart Failure Patients with Different Qrs Durations

Comparison of Efficacy of Reverse Remodeling and Clinical Improvement for Relatively Narrow and Wide QRS Complexes after Cardiac Resynchronization Therapy for Heart Failure

Value of QRS duration in predicting clinical response to cardiac resynchronization therapy in patients with end-stage heart failure

Prognostic Value of QRS Duration in Patients with Dilated Cardiomyopathy According to Left Ventricular Ejection Fraction

Prognostic Implications of QRS Duration in Third-Degree Atrioventricular Block Patients with Heart Failure Treated with Cardiac Resynchronization Therapy.

Cardiac Resynchronization Therapy by Left Bundle Branch Area Pacing in Patients with Heart Failure and Left Bundle Branch Block

Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias.

The Suboptimal QLV Ratio May Indicate the Need for a Left Bundle Branch Area Pacing-Optimized Cardiac Resynchronization Therapy Upgrade

Multivariate analyse of effects on cardiac resynchronization therapy in patients with heart failure

Evaluation of synchronized left ventricular pacing rate over biventricular pacing in cardiac resynchronization therapy